You are here:
Pharma
#Pharma
Get Alerts

Articles

View all

Nifty breaches 7,700 mark, Sensex at new high on fund inflows

Jun 11, 2014

Nifty breaches 7,700 mark, Sensex at new high on fund inflows

The NSE index Nifty today crossed the 7,700 level for the first time and the BSE Sensex hit yet another record high of 25,735.87 led by a rally in IT, auto banking and pharma stocks on sustained inflow of foreign capital. #Sensex #BSE Sensex #India #TCS #wipro #nifty #NewsTracker #Sun Pharma #markets #Hang Seng Index
Andhra HC vacates status quo order on Sun Pharma-Ranbaxy merger

May 24, 2014

Andhra HC vacates status quo order on Sun Pharma-Ranbaxy merger

The Andhra Pradesh High Court on Saturday vacated the status quo order it had issued earlier on the merger process between Sun Pharma and Ranbaxy. #Sensex #India #NewsTracker #Sun Pharma #BSE #Ranbaxy #Andhra Pradesh High Court
Decide on Ranbaxy-Sun Pharma merger in 2 days: SC to Andhra HC

May 21, 2014

Decide on Ranbaxy-Sun Pharma merger in 2 days: SC to Andhra HC

The pharmaceutical giants approached the court seeking its direction to vacate interim order on the High Court which had on 25 April stayed the merger and ordered status quo. #India #Business #NewsTracker #Sun Pharma #Supreme Court #pharmaceuticals #Ranbaxy #Merger #Andhra High Court
Nearly 30,000 packs of allergy-relief drug recalled by Ranbaxy in US

May 02, 2014

Nearly 30,000 packs of allergy-relief drug recalled by Ranbaxy in US

All other Ranbaxy plants, based in India, have been banned from exporting generics to the United States after the FDA found manufacturing quality glitches #World #India #US #NewsTracker #Dr Reddy's #Sun Pharma #pharmaceuticals #Ranbaxy #US FDA #DCGI #Exporting medicines #ban on Indian pharma drugs
Decoder: What Sun Pharma's $4 bn buyout of Ranbaxy is all about

Apr 07, 2014

Decoder: What Sun Pharma's $4 bn buyout of Ranbaxy is all about

The combination of the two will create the fifth-largest generic pharma company in the world and the largest pharmaceutical company in India and leave Daiichi Sankyo with a significant stake in the combined entity. #deal #Sun Pharma #Ranbaxy #Daiichi Sankyo #Pharmaceutical company

BLOG POSTS

View all

Its not just Ranbaxy, our health care regulators have failed us too

May 23, 2013

Its not just Ranbaxy, our health care regulators have failed us too

The Ranbaxy saga of fraud and greed goes beyond that. In India, it shows how our regulators too have failed us. #TheLongView #Health #Drugs #Ranbaxy #Healthcare #Pharma
Why a global fight against cancer is a good idea

Apr 10, 2013

Why a global fight against cancer is a good idea

In a substantive paper published today in the journal Nature Reviews, a group of authors from Singapore, the USA and Brazil evaluate the cost of cancer medication in low and middle income countries. #WhyNow #Cancer #Healthcare #Diabetes #Novartis #glivec #Merck #Dabur Pharma

Wire

View all

Why a global fight against cancer is a good idea

Jul 03, 2014

Facebook’s Controversial Experiment: Big Tech Is the New Big Pharma

Research in digital media is turning data science into human subjects research...
Why a global fight against cancer is a good idea

Jul 06, 2014

Brunner Investment Trust: Investors enjoy rising dividends for 42 years

Top contributors to the trust’s recent performance include Intercontinental Hotels and Astellas Pharma, which makes a drug used to treat prostate cancer...
Why a global fight against cancer is a good idea

Jun 28, 2014

Prospective Valeant-Allergan deal goes bipolar

The daily war of words between Valeant, the upstart Canadian pharma giant, and Allergan, the maker of Botox that Valeant is trying to buy in a hostile takeover, could make.....